---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-081675"
form_type: "8-K"
ticker: "CBRRF"
cik: "0001845149"
company_name: "Chain Bridge I"
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T18:11:08.808071+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Chain Bridge I to merge with Phytanix Bio at $58M equity value, ticker to become PHYX

## Summary
- Business Combination Agreement signed July 22, 2024; closing expected Q4 2024.
- Equity value of $58 million; HoldCo to issue Series A convertible preferred stock and exchange debt.
- HoldCo (New Phytanix) will list on Nasdaq under ticker PHYX after closing.
- Conditional on $100M equity line of credit with Keystone Capital Partners and $5M+ net tangible assets.
- Lock-up period for sponsor and certain stockholders: 365 days after close (6 months for independent directors).

## SEC filing metadata
- accession: 0001104659-24-081675
- form_type: 8-K
- ticker: CBRRF
- cik: 0001845149
- company_name: Chain Bridge I
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845149/000110465924081675/0001104659-24-081675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845149/000110465924081675/tm2419943d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-081675
- JSON: https://secwatch.observer/filing/0001104659-24-081675.json
- Plain text: https://secwatch.observer/filing/0001104659-24-081675.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.